Literature DB >> 16772844

Chronic stomal variceal bleeding after colonic surgery in patients with portal hypertension: efficacy of beta-blocking agents?

Myrène Noubibou1, Hortense C Douala, Patrick M Druez, Alex H Kartheuser, Alex H Kartheuzer, Roger J Detry, André P Geubel.   

Abstract

In patients with portal hypertension, ileostomy or colostomy carries the risk of the development of stomal varices at the site of the mucocutaneous junction of a stoma. Such varices are often the source of difficult-to-treat recurrent or chronic bleeding. In this setting, transjugular intrahepatic portosystemic shunt insertion and embolisation is considered the best therapeutic approach in spite of relatively high mortality and morbidity rates. We report the cases of three consecutive patients with portal hypertension of various causes and chronic stomal variceal bleeding in whom beta-blocking therapy resulted in the drying up of bleeding and the prevention of its recurrence for periods of time ranging between 2 and 42 months.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16772844     DOI: 10.1097/01.meg.0000224480.74298.0a

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  4 in total

Review 1.  Ostomy-Related Complications.

Authors:  Douglas R Murken; Joshua I S Bleier
Journal:  Clin Colon Rectal Surg       Date:  2019-04-02

2.  Updates in the pathogenesis, diagnosis and management of ectopic varices.

Authors:  Ahmed Helmy; Khalid Al Kahtani; Mohamed Al Fadda
Journal:  Hepatol Int       Date:  2008-05-31       Impact factor: 6.047

Review 3.  Management of parastomal varices: who re-bleeds and who does not? A systematic review of the literature.

Authors:  M O Pennick; D Y Artioukh
Journal:  Tech Coloproctol       Date:  2012-11-14       Impact factor: 3.781

4.  Hemorrhagic ascites from spontaneous ectopic mesenteric varices rupture in NASH induced cirrhosis and successful outcome: a case report.

Authors:  Raja G R Edula; Kamran Qureshi; Hicham Khallafi
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.